The benefits and hazards of antioxidants: Controlling apoptosis and other protective mechanisms in cancer patients and the human population

Authors
Citation
Ri. Salganik, The benefits and hazards of antioxidants: Controlling apoptosis and other protective mechanisms in cancer patients and the human population, J AM COL N, 20(5), 2001, pp. 464S-472S
Citations number
54
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
ISSN journal
07315724 → ACNP
Volume
20
Issue
5
Year of publication
2001
Supplement
S
Pages
464S - 472S
Database
ISI
SICI code
0731-5724(200110)20:5<464S:TBAHOA>2.0.ZU;2-3
Abstract
Cellular oxidants, called reactive oxygen species (ROS), are constantly pro duced in animal and human cells. Excessive ROS can induce oxidative damage in cell constituents and promote a number of degenerative diseases and agin g. Cellular antioxidants protect against the damaging effects of ROS. Howev er, in moderate concentrations. ROS are necessary for a number of protectiv e reactions. Thus, ROS are essential mediators of antimicrobial phagocytosi s, detoxification reactions carried out by the cytochrome P-450 complex, an d apoptosis which eliminates cancerous and other life-threatening cells. Ex cessive antioxidants could dangerously interfere with these protective func tions, while temporary depletion of antioxidants can enhance anti-cancer ef fects of apoptosis. Experimental data are presented supporting these notion s. The human population is heterogeneous regarding ROS levels. Intake of ex ogenous antioxidants (vitamins E, C. beta-carotene and others) could protec t against cancer and other degenerative diseases in people with innate or a cquired high levels of ROS. However, abundant antioxidants might suppress t hese protective functions. particularly in people with a low innate baselin e level of ROS. Screening human populations for ROS levels could help ident ify groups with a high level of ROS that are at a risk of developing cancer and other degenerative diseases. It also could identify groups with a low level of ROS that are at a risk of down-regulating ROS-dependent anti-cance r and other protective reactions. Screening populations could provide a sci entifically grounded application of antioxidant supplements, which could si gnificantly contribute to the nation's health.